Free Trial
NASDAQ:VIRI

Virios Therapeutics (VIRI) Stock Price, News & Analysis

Virios Therapeutics logo
$4.89 +0.14 (+2.86%)
As of 08/7/2025

About Virios Therapeutics Stock (NASDAQ:VIRI)

Key Stats

Today's Range
$4.75
$5.08
50-Day Range
$4.50
$5.60
52-Week Range
$0.13
$1.04
Volume
31,130 shs
Average Volume
1.05 million shs
Market Capitalization
$94.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.00
Consensus Rating
Hold

Company Overview

Receive VIRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virios Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

VIRI Stock News Headlines

Dogwood Therapeutics Inc (DWTX)
Dogwood prices 578,950 shares at $8.26 in registered direct offering
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).
Dogwood announces conversion of existing $19.5M in debt to equity
DWTX Stock trading resumes
Dogwood Therapeutics, Inc. (DWTX)
DWTX Stock trading halted, volatility trading pause
See More Headlines

VIRI Stock Analysis - Frequently Asked Questions

Virios Therapeutics' stock was trading at $2.49 at the start of the year. Since then, VIRI stock has increased by 96.5% and is now trading at $4.8920.

Virios Therapeutics, Inc. (NASDAQ:VIRI) posted its quarterly earnings results on Thursday, August, 8th. The company reported ($0.05) earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.02.

Virios Therapeutics (VIRI) raised $30 million in an IPO on Thursday, December 17th 2020. The company issued 3,000,000 shares at a price of $9.00-$11.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.

Shares of VIRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Virios Therapeutics investors own include Meta Platforms (META), AMC Entertainment (AMC), SNDL (SNDL), CISO Global (CISO), Canoo (GOEV), Organigram Global (OGI).

Company Calendar

Last Earnings
8/08/2024
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VIRI
CIK
1818844
Fax
N/A
Employees
5
Year Founded
N/A

Price Target and Rating

High Price Target
$5.00
Low Price Target
$5.00
Potential Upside/Downside
+2.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.27)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$5.30 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-130.33%
Return on Assets
-115.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
7.27
Quick Ratio
7.27

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.20 per share
Price / Book
24.46

Miscellaneous

Outstanding Shares
19,258,000
Free Float
16,909,000
Market Cap
$94.21 million
Optionable
Optionable
Beta
1.58

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:VIRI) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners